The curious case of a catatonic patient.
Enterman
John H
JH
Department Parnassia, Klinisch Centrum Volwassenen Gesloten (Clinical Centre for Adults), DH Den Haag, The Netherlands. j.enterman@parnassia.nl
van Dijk
Dyllis
D
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D003131:Combined Modality Therapy; D003692:Delayed-Action Preparations; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005475:Flupenthixol / Q000031:analogs & derivatives / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use*; D008297:Male; D012008:Recurrence; D012560:Schizophrenia, Catatonic / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; C007761:flupenthixol decanoate; D005475:Flupenthixol; D008140:Lorazepam